Stocktoria
Tectonic Therapeutic, Inc. TECX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-06-21
Tectonic Therapeutic, Inc. statistics & valuation
Market cap$603.6M
P / B2.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -28.4% | -37.9% | -108.7% | -101.9% | -58.4% |
| Return on equity | -29.5% | -41.2% | 50.6% | 231.9% | -70.3% |
| Debt / equity | — | — | — | -0.33× | 0.09× |
| Current ratio | 26.63 | 12.65 | 0.76 | 7.62 | 10.27 |
Source: SEC EDGAR filings · CIK 0001681087 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.